Arrowstreet Capital’s GoodRx Holdings GDRX Stock Holding History

Arrowstreet Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-53,177	Closed	-$265K	–	1969
2025 Q2	$265K	Hold	53,177	–	–	﹤0.01%	1848
2025 Q1	$235K	Buy	+53,177	New	+$250K	﹤0.01%	1726
2024 Q2	–	Sell	-377,276	Closed	-$2.68M	–	1610
2024 Q1	$2.68M	Buy	+377,276	New	+$2.5M	﹤0.01%	1060
2023 Q4	–	Sell	-99,000	Closed	-$557K	–	1457
2023 Q3	$557K	Buy	+99,000	New	+$660K	﹤0.01%	1089
2023 Q2	–	Sell	-490,585	Closed	-$3.07M	–	1312
2023 Q1	$3.07M	Buy	490,585 +327,270	+200%	+$1.82M	﹤0.01%	812
2022 Q4	$761K	Sell	163,315 -256,214	-61%	-$1.26M	﹤0.01%	1068
2022 Q3	$1.96M	Buy	+419,529	New	+$2.64M	﹤0.01%	854

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital's GDRX Position: Q3 2025 in Review

Arrowstreet Capital sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 53,177 shares — an estimated $265K sold.

Arrowstreet Capital first reported a position in GDRX in Q3 2022 and held it in 7 quarters. The position peaked at $3.07M in Q1 2023. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

Arrowstreet Capital reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
Arrowstreet Capital sold 53,177 GoodRx Holdings shares in Q3 2025, an estimated $265K.
Arrowstreet Capital first reported a position in GoodRx Holdings in Q3 2022 and held it in 7 quarters.
Arrowstreet Capital's GoodRx Holdings position peaked at $3.07M in Q1 2023.
161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.